Literature DB >> 11071754

Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.

M Amit1, M K Carpenter, M S Inokuma, C P Chiu, C P Harris, M A Waknitz, J Itskovitz-Eldor, J A Thomson.   

Abstract

Embryonic stem (ES) cell lines derived from human blastocysts have the developmental potential to form derivatives of all three embryonic germ layers even after prolonged culture. Here we describe the clonal derivation of two human ES cell lines, H9.1 and H9.2. At the time of the clonal derivation of the H9.1 and H9.2 ES cell lines, the parental ES cell line, H9, had already been continuously cultured for 6 months. After an additional 8 months of culture, H9.1 and H9.2 ES cell lines continued to: (1) actively proliferate, (2) express high levels of telomerase, and (3) retain normal karyotypes. Telomere lengths, while somewhat variable, were maintained between 8 and 12 kb in high-passage H9.1 and H9.2 cells. High-passage H9.1 and H9.2 cells both formed teratomas in SCID-beige mice that included differentiated derivatives of all three embryonic germ layers. These results demonstrate the pluripotency of single human ES cells, the maintenance of pluripotency during an extended period of culture, and the long-term self-renewing properties of cultured human ES cells. The remarkable developmental potential, proliferative capacity, and karyotypic stability of human ES cells distinguish them from adult cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071754     DOI: 10.1006/dbio.2000.9912

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  349 in total

1.  Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity.

Authors:  Hiroshi Kawasaki; Hirofumi Suemori; Kenji Mizuseki; Kiichi Watanabe; Fumi Urano; Hiroshi Ichinose; Masatoshi Haruta; Masayo Takahashi; Kanako Yoshikawa; Shin-Ichi Nishikawa; Norio Nakatsuji; Yoshiki Sasai
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 2.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 3.  Extrinsic regulation of pluripotent stem cells.

Authors:  Martin F Pera; Patrick P L Tam
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 4.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

5.  Cytochemical and ultrastructural characterization of growing colonies of human embryonic stem cells.

Authors:  Kohei Johkura; Li Cui; Kazuhiko Asanuma; Yasumitsu Okouchi; Naoko Ogiwara; Katsunori Sasaki
Journal:  J Anat       Date:  2004-10       Impact factor: 2.610

Review 6.  Embryonic stem cells.

Authors:  H J Rippon; A E Bishop
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

7.  Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate.

Authors:  Carolin Steffenhagen; Franz-Xaver Dechant; Eleni Oberbauer; Tanja Furtner; Norbert Weidner; Patrick Küry; Ludwig Aigner; Francisco J Rivera
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

8.  Genetic instability in neural stem cells: an inconvenient truth?

Authors:  Neil J Harrison
Journal:  J Clin Invest       Date:  2012-01-24       Impact factor: 14.808

Review 9.  Signaling networks in human pluripotent stem cells.

Authors:  Stephen Dalton
Journal:  Curr Opin Cell Biol       Date:  2012-10-22       Impact factor: 8.382

10.  Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors.

Authors:  Jamie M Sperger; Xin Chen; Jonathan S Draper; Jessica E Antosiewicz; Chris H Chon; Sunita B Jones; James D Brooks; Peter W Andrews; Patrick O Brown; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.